# A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)

> **NCT07063238** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MK-8527
- **DRUG:** Moxifloxacin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07063238
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-12
- **Primary completion:** 2025-12-06
- **Final completion:** 2025-12-29
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07063238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07063238, "A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07063238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*